Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: Evaluation of possible serotonergic and dopaminergic underlying mechanisms

Frontiers in Pharmacology

Volumn 5 MAR, Issue , 2014, Pages

  Amchova, Petra ^a   Kucerova, Jana ^a   Giugliano, Valentina ^b   Babinska, Zuzana ^a   Zanda, Mary T ^b   Scherma, Maria ^b   Dusek, Ladislav ^a   Fadda, Paola ^b   Micale, Vincenzo ^a   Sulcova, Alexandra ^a   Fratta, Walter ^b   Fattore, Liana ^b,c  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c CNR   (Italy)

Author keywords

Cannabinoid; Depression; Dopamine; Drug dependence; Methamphetamine; Olfactory bulbectomy; Serotonin; WIN55212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (4 METHYL 1 PIPERAZINYL) 7 TRIFLUOROMETHYLPYRROLO[1,2 A]QUINOXALINE; METHAMPHETAMINE; UNCLASSIFIED DRUG; WIN 55 2122;

ADULT; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; AVERSIVE BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; IN VIVO STUDY; INSTRUMENTAL CONDITIONING; LOCOMOTION; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULBECTOMY; RAT; REINFORCEMENT; ROOM TEMPERATURE; SEROTONINERGIC SYSTEM;

EID: 84897934250     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00044     Document Type: Article

References (83)

1. Arendt, M., Rosenberg, R., Fjordback, L., Brandholdt, J., Foldager, L., Sher, L., et al. (2007). Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects. Psychol. Med. 37, 935-945. doi: 10.1017/S0033291706009688.
2. Ashton, C. H., and Moore, P. B. (2011). Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatr. Scand. 124, 250-261. doi: 10.1111/j.1600-0447.2011.01687.x.
3. Baker, A. L., Hides, L., and Lubman, D. I. (2010). Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review. J. Clin. Psychiatry 71, 247-254. doi: 10.4088/JCP.09r05119gry.
4. Barnes, N. M., and Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083-1152. doi: 10.1016/S0028-3908(99)00010-6.
5. Becker, J. B., Perry, A. N., and Westenbroek, C. (2012). Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis. Biol. Sex. Differ. 3:14. doi: 10.1186/2042-6410-3-14.
6. Beyer, C. E., Dwyer, J. M., Piesla, M. J., Platt, B. J., Shen, R., Rahman, Z., et al. (2010). Depression-like phenotype following chronic CB1 receptor antagonism. Neurobiol. Dis. 39, 148-155. doi: 10.1016/j.nbd.2010.03.02.
7. Cai, X., Kallarackal, A. J., Kvarta, M. D., Goluskin, S., Gaylor, K., Bailey, A. M., et al. (2013). Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression. Nat. Neurosci. 16, 464-472. doi: 10.1038/nn.3355.
8. Calcagnetti, D. J., Quatrella, L. A., and Schechter, M. D. (1996). Olfactory bulbectomy disrupts the expression of cocaine-induced conditioned place preference. Physiol. Behav. 59, 597-604. doi: 10.1016/0031-9384(95)02119-1.
9. Castelli, M. P., Fadda, P., Casu, A., Spano, M. S., Casti, A., Fratta, W., et al. (2013). Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones. Curr. Pharm. Des. 19, 1-14. doi: 10.2174/13816128113199990430.
10. Chambers, R. A., Sheehan, T., and Taylor, J. R. (2004). Locomotor sensitization to cocaine in rats with olfactory bulbectomy. Synapse 52, 167-175. doi: 10.1002/syn.20017.
11. Cheer, J. F., Wassum, K. M., Heien, M. L., Phillips, P. E., and Wightman, R. M. (2004). Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J. Neurosci. 24, 4393-4400. doi: 10.1523/JNEUROSCI.0529-04.2004.
12. Chiang, C. Y., Yeh, K. Y., Lin, S. F., Hsuchou, H., Tai, M. Y., Ho, Y. J., et al. (2008). Effects of alcohol on the mouse-killing behavior of olfactory bulbectomized rats. Chin. J. Physiol. 51, 408-413.
13. Czachowski, C. L. (2005). Manipulations of serotonin function in the nucleus accumbens core produce differential effects on ethanol and sucrose seeking and intake. Alcohol. Clin. Exp. Res. 29, 1146-1155. doi: 10.1097/01.ALC.0000171944.50381.86.
14. De Boer, S. F., and Koolhaas, J. M. (2005). 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. Eur. J. Pharmacol. 526, 125-139. doi: 10.1016/j.ejphar.2005.09.065.
15. Degenhardt, L., Hall, W., and Lynskey, M. (2003). Exploring the association between cannabis use and depression. Addiction 98, 1493-1504. doi: 10.1046/j.1360-0443.2003.00437.x.
16. Deiana, S., Fattore, L., Spano, M. S., Cossu, G., Porcu, E., Fadda, P., et al. (2007). Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats. Neuropharmacology 52, 646-654. doi: 10.1016/j.neuropharm.2006.09.007.
17. Fadda, P., Scherma, M., Spano, M. S., Salis, P., Melis, V., Fattore, L., et al. (2006). Cannabinoid self-administration increases dopamine release in the nucleus accumbens. Neuroreport 17, 1629-1632. doi: 10.1097/01.wnr.0000236853.40221.8e.
18. Fattore, L., Cossu, G., Martellotta, C. M., and Fratta, W. (2001). Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology (Berl.) 156, 410-416. doi: 10.1016/j.euroneuro.2009.09.004.
19. Fattore, L., Spano, M. S., Altea, S., Angius, F., Fadda, P., and Fratta, W. (2007). Cannabinoid self-administration in rats: sex differences and the influence of ovarian function. Br. J. Pharmacol. 152, 795-804. doi: 10.1038/sj.bjp.0707465.
20. Fletcher, P. J., and Korth, K. M. (1999). Activation of 5-HT1B receptors in the nucleus accumbens reduces amphetamine-induced enhancement of responding for conditioned reward. Psychopharmacology (Berl.) 142, 165-174. doi: 10.1007/s002130050876.
21. Gardner, E. L., and Lowinson, J. H. (1991). Marijuana's interaction with brain reward systems: update 1991. Pharmacol. Biochem. Behav. 40, 571-580. doi: 10.1016/0091-3057(91)90365-9.
22. Grant, K. A., Colombo, G., and Gatto, G. J. (1997). Characterization of the ethanol-like discriminative stimulus effects of 5-HT receptor agonists as a function of ethanol training dose. Psychopharmacology (Berl.) 133, 133-141. doi: 10.1007/s002130050383.
23. Gruber, A. J., Pope, H. G. Jr., and Brown, M. E. (1996). Do patients use marijuana as an antidepressant? Depression 4, 77-80. doi: 10.1002/(SICI)1522-7162(1996)4:2<77::AID-DEPR7>3.0.CO;2-C.
24. Hall, D. H., and Queener, J. E. (2007). Self-medication hypothesis of substance use: testing Khantzian's updated theory. J. Psychoactive Drugs 39, 151-158. doi: 10.1080/02791072.2007.10399873.
25. Harrison, A. A., Parsons, L. H., Koob, G. F., and Markou, A. (1999). RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist. Psychopharmacology (Berl.) 141, 242-250. doi: 10.1007/s002130050831.
26. Hayes, D. J., Graham, D. A., and Greenshaw, A. J. (2009). Effects of systemic 5-HT(1B) receptor compounds on ventral tegmental area intracranial self-stimulation thresholds in rats. Eur. J. Pharmacol. 604, 74-78. doi: 10.1016/j.ejphar.2008.12.023.
27. Hill, M. N., and Gorzalka, B. B. (2005). Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression? Behav. Pharmacol. 16, 333-352. doi: 10.1097/00008877-200509000-00006.
28. Holma, I. A., Holma, K. M., Melartin, T. K., Ketokivi, M., and Isometsa, E. T. (2013). Depression and smoking: a 5-year prospective study of patients with major depressive disorder. Depress. Anxiety 30, 580-588. doi: 10.1002/da.22108.
29. Holmes, P. V., Masini, C. V., Primeaux, S. D., Garrett, J. L., Zellner, A., Stogner, K. S., et al. (2002). Intravenous self-administration of amphetamine is increased in a rat model of depression. Synapse 46, 4-10. doi: 10.1002/syn.10105.
30. Horowitz, J. M., Kristal, M. B., and Torres, G. (1997). Differential behavioral responses to cocaethylene of Long-Evans and Sprague-Dawley rats: role of serotonin. Synapse 26, 11-21. doi: 10.1002/(SICI)1098-2396(199705)26:1<11::AID-SYN2>3.0.CO;2-H.
31. Horwood, L. J., Fergusson, D. M., Coffey, C., Patton, G. C., Tait, R., Smart, D., et al. (2012). Cannabis and depression: an integrative data analysis of four Australasian cohorts. Drug Alcohol Depend. 126, 369-378. doi: 10.1016/j.drugalcdep.2012.06.002.
32. Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., et al. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 46, 157-203.
33. Jentsch, J. D., and Taylor, J. R. (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl.) 146, 373-390. doi: 10.1007/PL00005483.
34. Justinova, Z., Tanda, G., Redhi, G. H., and Goldberg, S. R. (2003). Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology (Berl.) 169, 135-140. doi: 10.1007/s00213-003-1484-0.
35. Kamei, J., Hirose, N., Oka, T., Miyata, S., Saitoh, A., and Yamada, M. (2007). Effects of methylphenidate on the hyperemotional behavior in olfactory bulbectomized mice by using the hole-board test. J. Pharmacol. Sci. 103, 175-180. doi: 10.1254/jphs.FP0061021.
36. Kelly, J. P., Wrynn, A. S., and Leonard, B. E. (1997). The olfactory bulbectomized rat as a model of depression: an update. Pharmacol. Ther. 74, 299-316. doi: 10.1016/S0163-7258(97)00004-1.
37. Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry 142, 1259-1264.
38. Kucerova, J., Pistovcakova, J., Vrskova, D., Dusek, L., and Sulcova, A. (2012). The effects of methamphetamine self-administration on behavioural sensitization in the olfactory bulbectomy rat model of depression. Int. J. Neuropsychopharmacol. 15, 1503-1511. doi: 10.1017/S1461145711001684.
39. Kucerova, J., Vrskova, D., and Sulcova, A. (2009). Impact of repeated methamphetamine pretreatment on intravenous self-administration of the drug in males and estrogenized or non-estrogenized ovariectomized female rats. Neuro. Endocrinol. Lett. 30, 663-670.
40. Langas, A. M., Malt, U. F., and Opjordsmoen, S. (2010). Comorbid mental disorders in substance users from a single catchment area-a clinical study. BMC Psychiatry 11, 11-25. doi: 10.1186/1471-244X-11-25.
41. Lappalainen, J., Long, J. C., Eggert, M., Ozaki, N., Robin, R. W., Brown, G. L., et al. (1998). Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch. Gen. Psychiatry 55, 989-994. doi: 10.1001/archpsyc.55.11.989.
42. Leonard, B. E., and Tuite, M. (1981). Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. Int. Rev. Neurobiol. 22, 251-286. doi: 10.1016/S0074-7742(08)60295-0.
43. Lev-Ran, S., Roerecke, M., Le Foll, B., George, T. P., McKenzie, K., and Rehm, J. (2013). The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol. Med. 44, 1-14. doi: 10.1017/S0033291713001438.
44. Maciag, D., Coppinger, D., and Paul, I. A. (2006). Evidence that the deficit in sexual behavior in adult rats neonatally exposed to citalopram is a consequence of 5-HT1 receptor stimulation during development. Brain Res. 1125, 171-175. doi: 10.1016/j.brainres.2006.10.009.
45. Markou, A., Kosten, T. R., and Koob, G. F. (1998). Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 18, 135-174. doi: 10.1016/S0893-133X(97)00113-9.
46. Martellotta, M. C., Cossu, G., Fattore, L., Gessa, G. L., and Fratta, W. (1998). Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience 85, 327-330. doi: 10.1016/S0306-4522(98)00052-9.
47. Masini, C. V., Holmes, P. V., Freeman, K. G., Maki, A. C., and Edwards, G. L. (2004). Dopamine overflow is increased in olfactory bulbectomized rats: an in vivo microdialysis study. Physiol. Behav. 81, 111-119. doi: 10.1016/j.physbeh.2004.01.003.
48. Mato, S., Aso, E., Castro, E., Martin, M., Valverde, O., Maldonado, R., et al. (2007). CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors. J. Neurochem. 103, 2111-2120. doi: 10.1111/j.1471-4159.2007.04961.x.
49. Maurel, S., De Vry, J., and Schreiber, R. (1999). 5-HT receptor ligands differentially affect operant oral self-administration of ethanol in the rat. Eur. J. Pharmacol. 370, 217-223. doi: 10.1016/S0014-2999(99)00125-9.
50. Melis, M., and Pistis, M. (2007). Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? Curr. Neuropharmacol. 5, 268-277. doi: 10.2174/157015907782793612.
51. Micale, V., Di Marzo, V., Sulcova, A., Wotjak, C. T., and Drago, F. (2013a). Endocannabinoid system and mood disorders: priming a target for new therapies. Pharmacol. Ther. 138, 18-37. doi: 10.1016/j.pharmthera.2012.12.002.
52. Micale, V., Kucerova, J., and Sulcova, A. (2013b). Leading compounds for the validation of animal models of psychopathology. Cell Tissue Res. 354, 309-330. doi: 10.1007/s00441-013-1692-9.
53. Miryala, C. S., Hiegel, C., and Uphouse, L. (2013). Sprague-Dawley and Fischer female rats differ in acute effects of fluoxetine on sexual behavior. J. Sex. Med. 10, 350-361. doi: 10.1111/j.1743-6109.2012.02981.x.
54. Miszkiel, J., Adamczyk, P., Filip, M., and Przegalinski, E. (2012). The effect of serotonin 5HT1B receptor ligands on amphetamine self-administration in rats. Eur. J. Pharmacol. 677, 111-115. doi: 10.1016/j.ejphar.2011.12.033.
55. Moret, C., and Briley, M. (2000). The possible role of 5-HT(1B/D) receptors in psychiatric disorders and their potential as a target for therapy. Eur. J. Pharmacol. 404, 1-12. doi: 10.1016/S0014-2999(00)00581-1.
56. Murrough, J. W., Henry, S., Hu, J., Gallezot, J. D., Planeta-Wilson, B., Neumaier, J. F., et al. (2011). Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder. Psychopharmacology (Berl.) 213, 547-553. doi: 10.1007/s00213-010-1881-0.
57. Muscat, R., and Willner, P. (1989). Effects of dopamine receptor antagonists on sucrose consumption and preference. Psychopharmacology (Berl.) 99, 98-102. doi: 10.1007/BF00634461.
58. Neale, R. F., Fallon, S. L., Boyar, W. C., Wasley, J. W., Martin, L. L., Stone, G. A., et al. (1987). Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist. Eur. J. Pharmacol. 136, 1-9. 10.1016/0014-2999(87)90772-2.
59. Neisewander, J. L., Cheung, T. H., and Pentkowski, N. S. (2013). Dopamine D3 and 5-HT receptor dysregulation as a result of psychostimulant intake and forced abstinence: implications for medications development. Neuropharmacology 76:18. doi: 10.1016/j.neuropharm.2013.08.014.
60. Ogborne, A. C., Smart, R. G., Weber, T., and Birchmore-Timney, C. (2000). Who is using cannabis as a medicine and why: an exploratory study. J. Psychoactive Drugs 32, 435-443. doi: 10.1080/02791072.2000.10400245.
61. Oleson, E. B., and Cheer, J. F. (2012). A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harb. Perspect. Med. 2:a012229. doi: 10.1101/cshperspect.a012229. Available online at: http://perspectivesinmedicine.org/content/2/8.toc#PERSPECTIVES.
62. Otten, R., and Engels, R. C. (2013). Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene. Addict. Biol. 18, 826-835. doi: 10.1111/j.1369-1600.2011.00380.x.
63. Parsons, L. H., Weiss, F., and Koob, G. F. (1996). Serotonin1b receptor stimulation enhances dopamine-mediated reinforcement. Psychopharmacology (Berl.) 128, 150-160. doi: 10.1007/s002130050120.
64. Paxinos, G., and Watson, C. (1998). The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press.
65. Pentkowski, N. S., Cheung, T. H., Toy, W. A., Adams, M. D., Neumaier, J. F., and Neisewander, J. L. (2012). Protracted withdrawal from cocaine self-administration flips the switch on 5-HT(1B) receptor modulation of cocaine abuse-related behaviors. Biol. Psychiatry 72, 396-404. doi: 10.1016/j.biopsych.2012.03.024.
66. Polissidis, A., Galanopoulos, A., Naxakis, G., Papahatjis, D., Papadopoulou-Daifoti, Z., and Antoniou, K. (2013). The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently. Int. J. Neuropsychopharmacol. 16, 393-403. doi: 10.1017/S1461145712000156.
67. Prins, J., Olivier, B., and Korte, S. M. (2011). Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited. Expert Opin. Investig. Drugs 20, 1107-1130. doi: 10.1517/13543784.2011.594039.
68. Pytliak, M., Vargova, V., Mechirova, V., and Felsoci, M. (2011). Serotonin receptors-from molecular biology to clinical applications. Physiol. Res. 60, 15-25.
69. Rodriguez-Gaztelumendi, A., Rojo, M. L., Pazos, A., and Diaz, A. (2009). Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine. J. Neurochem. 108, 1423-1433. doi: 10.1111/j.1471-4159.2009.05898.x.
70. Romeas, T., Morissette, M. C., Mnie-Filali, O., Pineyro, G., and Boye, S. M. (2009). Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression. Psychopharmacology (Berl.) 205, 293-303. doi: 10.1007/s00213-009-1539-y.
71. Rotenberg, V. S. (1994). The revised monoamine hypothesis: mechanism of antidepressant treatment in the context of behavior. Integr. Physiol. Behav. Sci. 29, 182-188. doi: 10.1007/BF02691013.
72. Sato, A., Nakagawasai, O., Tan-No, K., Onogi, H., Niijima, F., and Tadano, T. (2010). Influence of olfactory bulbectomy on maternal behavior and dopaminergic function in nucleus accumbens in mice. Behav. Brain Res. 215, 141-145. doi: 10.1016/j.bbr.2010.07.012.
73. Song, C., and Leonard, B. E. (2005). The olfactory bulbectomised rat as a model of depression. Neurosci. Biobehav. Rev. 29, 627-647. doi: 10.1016/j.neubiorev.2005.03.01.
74. Spano, M. S., Fadda, P., Fratta, W., and Fattore, L. (2010). Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs. Curr. Drug Targets 11, 450-461. doi: 10.2174/138945010790980295.
75. Tanda, G., Pontieri, F. E., and Di Chiara, G. (1997). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276, 2048-2050. doi: 10.1126/science.276.5321.2048.
76. Tatarczynska, E., Klodzinska, A., Stachowicz, K., and Chojnacka-Wojcik, E. (2004). Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression. Behav. Pharmacol. 15, 523-534. doi: 10.1097/00008877-200412000-00001.
77. Testa, A., Giannuzzi, R., Sollazzo, F., Petrongolo, L., Bernardini, L., and Dain, S. (2013). Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases. Eur. Rev. Med. Pharmacol. Sci. 17(Suppl. 1), 65-85.
78. Tomkins, D. M., and O'Neill, M. F. (2000). Effect of 5-HT(1B) receptor ligands on self-administration of ethanol in an operant procedure in rats. Pharmacol. Biochem. Behav. 66, 129-136. doi: 10.1016/S0091-3057(00)00232-X.
79. Uphouse, L., Maswood, S., Jackson, A., Brown, K., Prullage, J., Myers, T., et al. (2002). Strain differences in the response to the 5-HT1A receptor agonist, 8-OH-DPAT. Pharmacol. Biochem. Behav. 72, 533-542. doi: 10.1016/S0091-3057(02)00714-1.
80. Van Riezen, H., and Leonard, B. E. (1990). Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. Pharmacol. Ther. 47, 21-34. doi: 10.1016/0163-7258(90)90043-2.
81. Vieyra-Reyes, P., Mineur, Y. S., Picciotto, M. R., Tunez, I., Vidaltamayo, R., and Drucker-Colin, R. (2008). Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression. Brain Res. Bull. 77, 13-18. doi: 10.1016/j.brainresbull.2008.05.007.
82. Vinklerova, J., Novakova, J., and Sulcova, A. (2002). Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251. J. Psychopharmacol. 16, 139-143. doi: 10.1177/026988110201600204.
83. Wohl, M., and Ades, J. (2009). [Depression and addictions: links and therapeutic sequence]. Rev. Prat. 59, 484-487.